This is wonderful news for people in chronic pain who either cannot or choose not to take pain medication. VIOXX and Celebrex have been taken off the market because of their negative side-effects.
Brooklyn, IA (PRWEB) February 6, 2006
A pilot study recently completed at the offices of Harrington Chiropractic, PC and Laser Therapy Center found that treatment with the Avicenna Class IV Therapeutic Laser is effective at managing chronic knee pain. Dr. Phil Harrington, a pioneer in the field of laser therapy in the state of Iowa, commented, "This is wonderful news for people in chronic pain who either cannot or choose not to take pain medication. VIOXX and Celebrex have been taken off the market because of their negative side-effects." Also, a recent study found acetaminophen to be the leading cause of acute liver failure in the US.
Dr. Harrington continued, "Avicenna laser therapy has extremely minimal side effects; and yet it promises to have substantial benefit for patients with knee and other joint pain, as well as a myriad of other neuromusculoskeletal conditions." The Avicenna laser works by enhancing tissue elasticity, promoting energy production from damaged cells and by elevating cell membrane permeability. This can give a patient greater mobility, reduced pain, and a faster rate of healing.
In the study, ten people were randomly selected from an applicant pool of twenty-three. All people were at least fifty years old and had chronic knee pain – defined as knee pain of more than two months duration. People who were candidates for knee replacement were excluded from the study.
Over a two week period, five of the people received a seven minute application of the Avicenna Class IV Therapeutic Laser on their knee. The other five received application of an ordinary heat lamp for seven minutes. A towel was draped across the supine patient, blocking line of sight to their knee. Patients received a total of six treatments in two weeks.
Patients rated their level of pain in the knee on a visual analog scale, which was then plotted on a graph and statistical analysis was used to plot a trend line. The trend lines of patients receiving Avicenna laser therapy consistently went down, indicating a reduction in their knee pain.
The most beneficial factor of laser therapy is that it has little or no side effects. Contrast that with the side effects pain killing drugs. Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to cause gastrointetinal bleeding. VIOXX has been withdrawn from the market due to concerns about heart attack and stroke.
We clearly need another answer for people in pain. The Avicenna Class IV Therapeutic Laser appears to be a viable and extremely safe alternative for sufferers of chronic knee pain. Clinical experience at the office of Dr. Harrington has shown the Avicenna laser to be an effective treatment for a number of other neuromusculoskeletal conditions.
More progressive doctors in all disciplines should be using the Avicenna Class IV Therapeutic Laser. According to the International Association for the Study of Pain, “Pain is a major healthcare problem. Although acute pain may reasonably be considered a symptom of disease or injury, chronic and recurrent pain is a specific healthcare problem, a disease in its own right.” (“Unrelieved Pain is a Major Global Healthcare Problem”, http://www.iasp-pain.org)
For more information, questions or comments about this study or the Avicenna Laser, contact Dr. Phil Harrington at 641-522-9220 or on his website at http://www.iowalaserdoctor.com.
# # #